Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1532 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Celgene–Evotec: drug discovery services, 201809– strategic RnD collab in field of targeted protein degradation using Panomics platform 2018-09-06
Genkyotex–Yorkville Group: credit, 201808– up to €7.5m convertible notes with attached warrants in 2 tranches with YA II PN Ltd 2018-08-20
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures 2018-08-10
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience 2018-08-10
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group 2018-08-10
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures 2018-08-10
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund 2018-08-10
Artios Pharma–Pfizer: investment, 201808 financing round Series B totalling $84m incl new + co-investor Pfizer Ventures 2018-08-10
Artios Pharma–SEVERAL: investment, 201808 financing round Series B $84m (£65m) led by new investors Andera Partners + LSP 2018-08-10
Artios Pharma–SV Health Investors: investment, 201808 financing round Series B totalling $84m incl existing + co-investor SV 2018-08-10
ReViral–Andera Partners: investment, 201808 financing round Series B totalling $55m incl existing + co-investor Andera Partners 2018-08-01
ReViral–EMS (BR): investment, 201808 financing round Series B totalling $55m incl existing + co-investor Brace Pharma Capital 2018-08-01
ReViral–OrbiMed Advisors: investment, 201808 financing round Series B totalling $55m incl existing + co-investor OrbiMed 2018-08-01
ReViral–SEVERAL: investment, 201808 financing round Series B $55m co-lead by new investors New Leaf Venture Partners + Novo Ventures 2018-08-01
Laboratorios Ecosur–Eurofins: investment, 201807 acquisition of Ecosur by Eurofins 2018-07-27
Nanobiotix–EU (govt): credit, 201807– up to €40m loan agreement with EIB over coming five years subjet to performance criteria 2018-07-26
TxCell–Sangamo: investment, 201807– acquisiton $72m in cash on cash/debt-free basis with simplified cash tender offer 2018-07-23
Adocia–MC Services: public relations, 201807 service existent PR Europe by MC Services 2018-07-18
Adocia–Ruth Group: public relations, 201807 service existent IR USA by The Ruth Group 2018-07-18
Sanofi–Revolution Medicines: SHP2 inhibitors, 201807– collab ww to develop SHP2 inhibitors incl RMC-4630 for multiple cancers 2018-07-18
Sohin (MX)–HalioDx: cancer test, 201807– distribution of Immunoscore Colon Assay in Mexico by Sohin 2018-07-16
Antabio–SEVERAL: investment, 201807 2nd closing financing round Series A €5.2m bringing total Series A to €12.5m 2018-07-12
Institut Pasteur–Thermo Fisher: transmission electron microscope, 201807 supply Krios Cryo-TEM system to Institut Pasteur in Paris 2018-07-12
Miltenyi Biotec–Scienion: cell handling technology, 201807– collab co-marketing MACSQuant Tyto Cell Sorter with cellenONE X1 Cell Dispenser 2018-07-12
Omnes Capital–Brackendale Consulting: public relations, 201807 service existent by Brackendale Consulting 2018-07-12
Yposkesi–Andrew Lloyd Associates: public relations, 201807 service existent by ALA 2018-07-09
Dynacure–Andera Partners: investment, 201807 financing round totalling €47m incl lead investor Andera Partners 2018-07-06
Dynacure–France (govt): investment, 201807 financing round totalling €47m incl co-investor Bpifrance 2018-07-06
Dynacure–Idinvest Partners: investment, 201807 financing round totalling €47m incl co-investor Idinvest Partners 2018-07-06
Dynacure–Kurma: investment, 201807 financing round totalling €47m incl co-investor Kurma Partners 2018-07-06
Dynacure–Pontifax: investment, 201807 financing round totalling €47m incl co-investor Pontifax 2018-07-06
Dynacure–SEVERAL: investment, 201807 financing round €47m led by Andera Partners + incl Pontifax + Bpifrance + Kurma + IdInvest 2018-07-06
IMMUNOMONITOR project–Biomax: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–Enpicom: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–EU (govt): grant, 201807– Eurostars grant €2m to develop clin validation for treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–OSE Immunotherapeutics: pharmacogenomics, 201807– collab project partner develop validation treatm response cancer vaccines 2018-07-05
IMMUNOMONITOR project–Ultimovacs: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response cancer vaccines 2018-07-05
IMMUNOMONITOR project–Univ Hamburg: pharmacogenomics, 201807– collab partner Eurostars in project develop validation treatm response cancer vaccines 2018-07-05
Netbiotix–Auriga: investment, 201807 financing round Series A totalling €7.5m incl lead investor Auriga Partners 2018-07-05
Netbiotix–Biocodex: investment, 201807 financing round Series A totalling €7.5m incl co-investor Biocodex 2018-07-05
Netbiotix–SEVERAL: investment, 201807 financing round Series A €7.5m led by Auriga Partners + incl Biocodex 2018-07-05
Nextbiotix–SEVERAL: investment, 201807 financing round Series A €7m led by Auriga Partners 2018-07-05
Nextbiotix–Ulysse Communication: public relations, 201807 service existent by Ulysse 2018-07-05
Laboratoire de Bromatologie de l’Ouest–Eurofins: investment, 201807 acquisition of LBO by Eurofins 2018-07-03
Pharma Omnium–NuPharm: investment, 201807 acquisition €na of Laboratoire Biodim from Pharma Omnium 2018-07-03
Mérieux–Deinove: antibiotics, 201806– collab antibotics drug discovery of bioMérieux + Deinove + AGIR project 2018-06-28
NodThera–5AM Ventures: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Epidarex Capital: investment, 201806 financing round Series A totalling £28m ($40m) incl existing co-investor Epidarex Capital 2018-06-25
NodThera–F-Prime: investment, 201806 financing round Series A totalling £28m ($40m) incl co-investor F-Prime Capital Partners 2018-06-25
NodThera–Selvita: investment, 201806 existing investor 2018-06-25
NodThera–SEVERAL: investment, 201806 financing round Series A £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Sofinnova: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
Erytech–JMP Securities: investor conference, 201806 supply service Erytech presents at JMP Securities 2018 Life Sciences Conference NY 2018-06-20
Interactive Biosoftware–Sophia Genetics: investment, 201806 acquisition of IBS by Sophia Genetics 2018-06-16
Onxeo–Nice & Green: investment, 201806–201903 equity line financing up to €5.4m with up to 4.7new shares 2018-06-15
Sanofi–Evotec: investment, 201806–201807 acquisition integration of Sanofi’s infectious disease RnD in Lyon into Evotec 2018-06-15
Deinove–SEVERAL: investment, 201806 capital increase €8.5m with 3.148 new shares at €2.7/share 2018-06-14
Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings 2018-06-12
Metafora Biosystems–EU (govt): grant, 201806– H2020 SME Instrument grant €3.2m for developm of blood test for early diagnosis of De Vivo disease 2018-06-11
Enyo Pharma–Andera Partners: investment, 201806 financing round Series B totalling €40m incl new + co-investor Andera Partners 2018-06-04
Enyo Pharma–France (govt): investment, 201806 financing round Series B totalling €40m incl Bpifrance Large Venture + InnoBio + ITI 2018-06-04
Enyo Pharma–Morningside: investment, 201806 financing round Series B totalling €40m incl existing investor Morningside Venture Investments 2018-06-04
Enyo Pharma–Orbimed Advisors: investment, 201806 financing round Series B totalling €40m incl new + lead investor OrbiMed Private Investment VII 2018-06-04
Enyo Pharma–SEVERAL: investment, 201806 financing round Series B €40m led by new investor OrbiMed + incl Andera Partners + Bpifrance et al 2018-06-04
Enyo Pharma–Sofinnova: investment, 201806 financing round Series B totalling €40m incl existing investor Sofinnova Private Capital VII 2018-06-04
TxCell–Lonza: cell therapy contract manufacturing, 201805– supply of TX200 for clinical studies by Lonza production site in Geleen (NL) 2018-05-31
Apix Analytics–DataApex: chromatography s/w, 201805– distribution Apix Analytics to market PixL Lab OEM version of Clarity s/w 2018-05-30
Voluntis–SEVERAL: investment, 201805 IPO €30.1m at Euronext Paris with 2.15m new shares at €14/share 2018-05-30
Sanofi–Adaptive Biotechnologies: pharmacogenomics, 2010805– collab €na use of NGS-based clonoSEQ Assay in multiple myeloma trials of isatuximab 2018-05-29
Pierre Fabre–Roche: companion diagnostics, 201805– collab extension for developm of IHC CDx assay for ADC W0101 2018-05-18
Cellectis–SEVERAL: investment, 201805 public offering of Calyxt Inc $60.9m 4.6m+457k shares common stockat $15/share 2018-05-15
Pierre Fabre–BioSerenity: medical device, 201805– collab €na develop + marketing connected device for managing urinary incontinence 2018-05-14
PHAST–Eurofins: investment, 201805 acquisition of PHAST GmbH by Eurofins Scientific 2018-05-09
Harvard Univ–Cellectis: gene editing technology, 201805– collab Wyss Institute to use TALEN to recode a human genome 2018-05-01
Crescendo Biologics–SEVERAL: investment, 201805 financing round Series B €57m led by Andera Partners 2018-04-30
LabCorp–Eurofins: investment, 201804– acquisition $670m cash/debt free of Covance Food Solutions from LabCorp by Eurofins 2018-04-30
EryDel–SEVERAL: investment, 201804 financing round €26.5m led by Sofinnova Partners + incl Genextra + Innogest SGR 2018-04-24
EryDel–Sofinnova: investment, 201804 financing round totalling €26.5m inc lead investor Sofinnova Partners 2018-04-24
Onxeo–LifeSci: public relations, 201804 service existent IR US by LifeSci Advisors 2018-04-24
Onxeo–NewCap: public relations, 201804 service existent IR + strategic communication by NewCap 2018-04-24
LimFlow–SEVERAL: investment, 201804 financing round Series C €27m led by Sofinnova Crossover I Fund 2018-04-16
Shire–Servier: investment, 201804– acquisition of Shire’s oncology business for $2.4b in cash by Servier ANNOUNCED 2018-04-16
Biovertis–Deinove: investment, 201804–201805 acquisition of Biovertis/Morphochem for €900k in 500k new shares + 8m warrants 2018-04-13
Protec–Eurofins: investment, 201804 acquisition of Protec’s water + food testing business in France by Eurofins 2018-04-12
Allecra Therapeutics–HC Wainwright: investor conference, 201804 supply service Allecra presents at HC Wainwright Global Life Sciences Conference 2018-04-08
Curetis–HC Wainwright: investor conference, 201804 supply service Curetis presents at HC Wainwright Global Life Sciences Conference in Monte Carlo 2018-04-08
Astute Medical–Mérieux: investment, 201804 acquisition $90m in cash by bioMérieux 2018-04-04
Boehringer–OSE Immunotherapeutics: antibody cancer drug, 201804– collab + license ww OSE-172 €30m upfront+short-term + €1.1b milestones + royalties 2018-04-04
Eichrom Laboratoires–Eurofins: investment, 201804 acquisition by Eurofins 2018-04-04
LCF Rothschild–Andera Partners: investment, 201804 management buy-out of EdRIP by employees + renaming to Andera Partners 2018-04-04
Sofinnova–SEVERAL: investment, 201804 1st closing €275m of Sofinnova Crossover I fund 2018-04-04
Allogene Therapeutics–Cellectis: T-cell immunotherapy, 201804– collab continuation of Pfizer-Cellectis collaboration signed 201406 by Allogene 2018-04-03
Cellectis–SEVERAL: investment, 201804 public offering $175m ($163.7m net) with 5.646m ADSs at $31/ADS 2018-04-03
Young In Group–Eurofins: investment, 201804 acquisition of Lab Frontier Co Ltd from YIG by Eurofins 2018-04-03
Deinove–Redx Pharma: antibiotics, 201803– option + license agreem for Redx’ Novel Bacterial Topoisomerase Inhibitor programme 2018-03-22
DBV Technologies–SEVERAL: investment, 201803 global offering $172.5m public offering ADSs at $21.26 + private placement ordinary shares at €34.71 2018-03-20
Mérieux–Sartorius: bioreactors, 201803 supply of single-use viral vector manufacturing package to ABL Europe in Strasboug by SSB 2018-03-16
Valbiotis–Actifin: public relations, 201803 service financial communication existent by Actifin 2018-03-15
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x102px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

» top